Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Scheltema MJ"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 22
Tytuł:
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
Autorzy:
Ong S; EJ Whitten Foundation Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Vic., Australia.; Department of Surgery, University of Melbourne, Melbourne, Vic., Australia.
Chen K; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Urology, Singapore General Hospital, Singapore City, Singapore.
Grummet J; Department of Surgery, Central Clinical School, Monash University, Melbourne, Vic., Australia.
Yaxley J; The University of Queensland, School of Medicine, Brisbane, QLD, Australia.; Wesley Urology Clinic, Wesley Hospital, Brisbane, QLD, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Scheltema MJ; St. Vincent's Prostate Cancer Research Centre, Darlinghurst, NSW, Australia.; Department of Urology, St Vincents Hospital and Campus, Sydney, NSW, Australia.
Stricker P; St. Vincent's Prostate Cancer Research Centre, Darlinghurst, NSW, Australia.; Department of Urology, St Vincents Hospital and Campus, Sydney, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Tay KJ; Department of Urology, Singapore General Hospital, Singapore City, Singapore.
Lawrentschuk N; EJ Whitten Foundation Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Vic., Australia.; Department of Surgery, University of Melbourne, Melbourne, Vic., Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Urology, Royal Melbourne Hospital, Melbourne, Vic., Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2023 Jan; Vol. 131 (1), pp. 20-31. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/therapy
Urology*
Male ; Humans ; United States ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
Autorzy:
van Riel LAMJG; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Geboers B; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Kabaktepe E; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Blazevski A; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Reesink DJ; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Stijns P; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Stricker PD; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Casanova J; Department of Urology, Instituto Valenciano de Oncologia, València, Spain.
Dominguez-Escrig JL; Department of Urology, Instituto Valenciano de Oncologia, València, Spain.
de Reijke TM; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Scheltema MJ; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Nov; Vol. 130 (5), pp. 611-618. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Erectile Dysfunction*/etiology
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Prostate-Specific Antigen ; Retrospective Studies ; Quality of Life ; Neoplasm Recurrence, Local/therapy ; Treatment Outcome ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Salvage Therapy/methods ; Electroporation/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
Autorzy:
Blazevski A; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Scheltema MJ; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; Department of Urology, Amsterdam UMC, Amsterdam, The Netherlands.
Amin A; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.
Thompson JE; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Lawrentschuk N; EJ Whitten Prostate Cancer Research Centre at Epworth Healthcare, Melbourne, Victoria, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Surgery, Olivia Newton-John Cancer Centre, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Stricker PD; St. Vincent's Prostate Cancer Centre, Darlinghurst, New South Wales, Australia.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Mar; Vol. 125 (3), pp. 369-378. Date of Electronic Publication: 2019 Dec 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Electroporation*
Ablation Techniques/*methods
Prostatic Neoplasms/*surgery
Biomedical Research ; Forecasting ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Autorzy:
Amin A; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Blazevski A; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Thompson J; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St George Clinical School, University of New South Wales, Sydney, NSW, Australia.
Scheltema MJ; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Department of Urology, UMC, Amsterdam, The Netherlands.
Hofman MS; Centre for Molecular Imaging, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.
Murphy D; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Lawrentschuk N; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Vic., Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Surgery, Austin Health, The University of Melbourne, Parkville, Vic., Australia.; Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic., Australia.
Sathianathen N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Kapoor J; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Woo HH; Sydney Adventist Hospital Clinical School, University of Sydney, Wahroonga, NSW, Australia.; Department of Uro-Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
Chalasani V; University of Sydney, Sydney, NSW, Australia.
Rasiah K; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Department of Urology, Royal North Shore Private Hospital, St Leonards, NSW, Australia.
van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Tang R; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.
Cusick T; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Stricker P; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Apr; Vol. 125 (4), pp. 515-524. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Surface*
Gallium Radioisotopes*
Glutamate Carboxypeptidase II*
Multiparametric Magnetic Resonance Imaging*
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms/*diagnostic imaging
Cross-Sectional Studies/methods ; Humans ; Male ; Multicenter Studies as Topic/methods ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostic accuracy of Ga-PSMA PET to mpMRI.
Autorzy:
Scheltema MJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.
Chang JI; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Stricker PD; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
van Leeuwen PJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, The Netherlands.
Nguyen QA; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Ho B; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
Delprado W; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.
Lee J; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
Thompson JE; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Cusick T; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Spriensma AS; Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.
Siriwardana AR; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Yuen C; St Vincent's Clinic, Darlinghurst, NSW, Australia.
Kooner R; St Vincent's Clinic, Darlinghurst, NSW, Australia.
Hruby G; Genesis Cancer Care, St Vincent's Hospital, Darlinghurst, NSW, Australia.
O'Neill G; St Vincent's Clinic, Darlinghurst, NSW, Australia.
Emmett L; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2019 Nov; Vol. 124 Suppl 1, pp. 42-49. Date of Electronic Publication: 2019 Jul 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiparametric Magnetic Resonance Imaging*
Positron Emission Tomography Computed Tomography*
Prostatectomy*
Gallium Radioisotopes/*pharmacology
Prostate/*pathology
Prostatic Neoplasms/*pathology
Radiopharmaceuticals/*pharmacology
Aged ; Dimensional Measurement Accuracy ; Health Care Surveys ; Humans ; Male ; Middle Aged ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/analysis ; Prostatic Neoplasms/diagnostic imaging ; ROC Curve ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
Autorzy:
Gielchinsky I; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Chang J; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Cusick T; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Delprado W; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.; School of Medicine, University of New South Wales, Kensington, NSW, Australia.
Nguyen Q; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Yuen C; School of Medicine, University of New South Wales, Kensington, NSW, Australia.; St Vincent's Clinic, Sydney, NSW, Australia.
Savdie R; School of Medicine, University of New South Wales, Kensington, NSW, Australia.; St Vincent's Clinic, Sydney, NSW, Australia.
Böhm M; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Haynes AM; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Scheltema MJ; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Stricker PD; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; School of Medicine, University of New South Wales, Kensington, NSW, Australia.; St Vincent's Clinic, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2018 Nov; Vol. 122 Suppl 5, pp. 35-41. Date of Electronic Publication: 2018 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatectomy*
Watchful Waiting*
Prostatic Neoplasms/*pathology
Prostatic Neoplasms/*therapy
Disease-Free Survival ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasm, Residual ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Retrospective Studies ; Risk Assessment/methods ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Focal irreversible electroporation as primary treatment for localized prostate cancer.
Autorzy:
van den Bos W; Garvan Institute of Medical Research and Kinghorn Cancer Centre.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Scheltema MJ; Garvan Institute of Medical Research and Kinghorn Cancer Centre.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Siriwardana AR; Garvan Institute of Medical Research and Kinghorn Cancer Centre.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Kalsbeek AMF; Garvan Institute of Medical Research and Kinghorn Cancer Centre.
Thompson JE; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Ting F; Garvan Institute of Medical Research and Kinghorn Cancer Centre.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Böhm M; Garvan Institute of Medical Research and Kinghorn Cancer Centre.
Haynes AM; Garvan Institute of Medical Research and Kinghorn Cancer Centre.
Shnier R; Southern Radiology, Randwick.
Delprado W; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.
Stricker PD; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2018 May; Vol. 121 (5), pp. 716-724. Date of Electronic Publication: 2017 Sep 04.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Electroporation*/methods
Ablation Techniques/*methods
Neoplasm Recurrence, Local/*therapy
Prostate/*pathology
Prostatic Neoplasms/*therapy
Aged ; Feasibility Studies ; Humans ; Male ; Middle Aged ; Patient Safety ; Prospective Studies ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
Autorzy:
Scheltema MJ; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
van den Bos W; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Siriwardana AR; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Kalsbeek AMF; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Thompson JE; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Ting F; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Böhm M; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Haynes AM; Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Shnier R; Southern Radiology, Randwick, NSW, Australia.
Delprado W; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.
Stricker PD; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2017 Nov; Vol. 120 Suppl 3, pp. 51-58. Date of Electronic Publication: 2017 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ablation Techniques/*adverse effects
Ablation Techniques/*methods
Neoplasm Recurrence, Local/*therapy
Prostatic Neoplasms/*therapy
Salvage Therapy/*adverse effects
Salvage Therapy/*methods
Aged ; Feasibility Studies ; Humans ; Male ; Neoplasm Recurrence, Local/epidemiology ; Prostatic Neoplasms/epidemiology ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates.
Autorzy:
Luzzago S; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Piccinelli ML; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy.
Mistretta FA; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Bianchi R; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Cozzi G; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Di Trapani E; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Cioffi A; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Catellani M; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Fontana M; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy.
Jannello LMI; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy.
Botticelli FMG; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Università degli Studi di Milano, Milan, Italy.
Marvaso G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Alessi S; Division of Radiology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Pricolo P; Division of Radiology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Ferro M; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Matei DV; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Jereczek-Fossa BA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Pathology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Petralia G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Precision Imaging and Research Unit, Department of Medical Imaging and Radiation Sciences, IEO European Institute of Oncology IRCCS, Milan, Italy.
de Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Musi G; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Apr; Vol. 129 (4), pp. 524-533. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate*/diagnostic imaging
Prostate*/pathology
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Humans ; Image-Guided Biopsy/methods ; Magnetic Resonance Imaging/methods ; Male ; Neoplasm Grading ; Retrospective Studies ; Watchful Waiting
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade.
Autorzy:
Hennes DMZB; Department of Urology, Melbourne Health, Royal Melbourne Hospital, Australia.
Sewell J; Department of Urology, Melbourne Health, Royal Melbourne Hospital, Australia.
Kerger M; Department of Surgery, University of Melbourne, Parkville, Australia.
Hovens CM; Department of Surgery, University of Melbourne, Parkville, Australia.
Peters JS; Department of Urology, Melbourne Health, Royal Melbourne Hospital, Australia.
Costello AJ; Department of Urology, Melbourne Health, Royal Melbourne Hospital, Australia.; Department of Surgery, University of Melbourne, Parkville, Australia.
Ryan A; TissuPath, Mount Waverley, Australia.
Corcoran NM; Department of Urology, Melbourne Health, Royal Melbourne Hospital, Australia.; Department of Surgery, University of Melbourne, Parkville, Australia.; Victorian Comprehensive Cancer Centre, Melbourne, Vic., Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Dec; Vol. 128 Suppl 3, pp. 45-51. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Grading*
Adenocarcinoma/*pathology
Adenocarcinoma/*surgery
Prostatic Neoplasms/*pathology
Prostatic Neoplasms/*surgery
Adenocarcinoma/blood ; Adenocarcinoma/diagnostic imaging ; Biopsy ; Humans ; Male ; Multiparametric Magnetic Resonance Imaging ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnostic imaging ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?
Autorzy:
Doan P; Department of Urology, Westmead Hospital, Westmead, NSW, Australia.
Graham P; Macquarie Business School, Macquarie University, Sydney, NSW, Australia.
Lahoud J; Department of Urology, Westmead Hospital, Westmead, NSW, Australia.
Remmers S; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.
Roobol MJ; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.
Kim L; Department of Urology, Westmead Hospital, Westmead, NSW, Australia.; Specialty of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Patel MI; Department of Urology, Westmead Hospital, Westmead, NSW, Australia.; Specialty of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Dec; Vol. 128 Suppl 3, pp. 36-44. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji:
Comparative Study; Journal Article; Validation Study
MeSH Terms:
Magnetic Resonance Imaging*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*pathology
Risk Assessment/*methods
Aged ; Area Under Curve ; Australia ; Biopsy/methods ; Calibration ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Perineum ; Prostate/diagnostic imaging ; Prostate/pathology ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Ethnic and socio-economic disparities in prostate cancer screening: lessons from New Zealand.
Autorzy:
Matti B; Department of Surgery, University of Auckland, Auckland, New Zealand.
Lyndon M; Centre for Medical and Health Sciences Education, University of Auckland, Auckland, New Zealand.
Zargar-Shoshtari K; Department of Surgery, University of Auckland, Auckland, New Zealand.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Dec; Vol. 128 Suppl 3, pp. 11-17. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Early Detection of Cancer/*statistics & numerical data
Healthcare Disparities/*economics
Healthcare Disparities/*ethnology
Native Hawaiian or Other Pacific Islander/*statistics & numerical data
Prostatic Neoplasms/*diagnosis
Adult ; Aged ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; New Zealand ; Poverty ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.
Autorzy:
Fujihara A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Iwata T; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Shakir A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Tafuri A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.; Department of Urology, University of Verona, Verona, Italy.
Cacciamani GE; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Gill K; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Ashrafi A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Ukimura O; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Desai M; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Duddalwar V; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.; Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Stern MS; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Aron M; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Palmer SL; Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Gill IS; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Abreu AL; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Jun; Vol. 127 (6), pp. 712-721. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Multiparametric Magnetic Resonance Imaging*
Watchful Waiting*
Prostatic Neoplasms/*classification
Prostatic Neoplasms/*diagnostic imaging
Aged ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/therapy ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy.
Autorzy:
Timm B; Department of Urology, Austin Health, Heidelberg, Vic., Australia.; North Eastern Urology, Heidelberg, Vic., Australia.
Farag M; Department of Urology, Austin Health, Heidelberg, Vic., Australia.
Liodakis P; Department of Urology, Austin Health, Heidelberg, Vic., Australia.; North Eastern Urology, Heidelberg, Vic., Australia.
Angus D; Department of Urology, Austin Health, Heidelberg, Vic., Australia.; North Eastern Urology, Heidelberg, Vic., Australia.
Lim Joon D; Department of Radiation Oncology, Austin Health, Heidelberg, Vic, Australia.
Bolton D; Department of Urology, Austin Health, Heidelberg, Vic., Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 May; Vol. 127 Suppl 1, pp. 23-29.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local/*pathology
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*pathology
Urethra/*pathology
Urinary Bladder/*pathology
Aged ; Anastomosis, Surgical ; Biopsy ; Clinical Decision-Making ; Decision Making, Shared ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/surgery ; Retrospective Studies ; Salvage Therapy ; Ultrasonography ; Urethra/surgery ; Urinary Bladder/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Funding of prostate magnetic resonance imaging leads to fewer biopsies and potential savings to health systems in the management of prostate cancer.
Autorzy:
Whish-Wilson T; Department of Surgery, St. Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.; Department of Surgery, The University of Melbourne, Melbourne, Vic., Australia.
Costello D; Department of Surgery, St. Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.; Department of Surgery, The University of Melbourne, Melbourne, Vic., Australia.
Finch S; Statistical Consulting Centre and Melbourne Statistical Consulting Platform, The University of Melbourne, Melbourne, Vic., Australia.
Sutherland T; Department of Surgery, The University of Melbourne, Melbourne, Vic., Australia.; Medical Imaging Department, St. Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.
Wong LM; Department of Surgery, St. Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.; Department of Surgery, The University of Melbourne, Melbourne, Vic., Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 May; Vol. 127 Suppl 1, pp. 6-12. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Health Care Costs*
Multiparametric Magnetic Resonance Imaging/*economics
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*pathology
Australia ; Biopsy/adverse effects ; Biopsy/statistics & numerical data ; Cost Savings ; Databases, Factual ; Financing, Government ; Humans ; Male ; Postoperative Complications/economics ; Postoperative Complications/etiology ; Prostate/pathology ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy.
Autorzy:
Franklin A; Wesley Medical Research, Wesley Hospital, University of Queensland.
Gianduzzo T; Buderim Private Hospital.
Yaxley J; Royal Brisbane and Women's Hospital, Wesley Hospital, University of Queensland.
Kua B; Wesley Hospital.
Coughlin G; Wesley Hospital.
Samaratunga H; Aquesta Pathology, University of Queensland.
Gianduzzo T; Wesley Hospital, University of Queensland.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Sep; Vol. 126 Suppl 1, pp. 6-11. Date of Electronic Publication: 2020 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Image-Guided Biopsy/*methods
Magnetic Resonance Imaging, Interventional/*methods
Prostate/*diagnostic imaging
Prostatic Neoplasms/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Prostate/pathology ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Not all prostate cancer is the same - patient perceptions: an Asia-Pacific region study.
Autorzy:
Akakura K; Department of Urology, Japan Community Health-care Organization (JCHO), Tokyo Shinjuku Medical Center, Tokyo, Japan.
Bolton D; Department of Urology, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.
Grillo V; Health Division, Kantar, Singapore City, Singapore.
Mermod N; The Janssen Pharmaceutical Companies of Johnson & Johnson, Asia Pacific, Beerse, Belgium.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Sep; Vol. 126 Suppl 1, pp. 38-45. Date of Electronic Publication: 2020 Aug 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Health Knowledge, Attitudes, Practice*
Prostatic Neoplasms/*psychology
Aged ; Australia ; Communication ; Decision Making, Shared ; Disease Progression ; Emotions ; Asia, Eastern ; Humans ; Interviews as Topic ; Male ; Patient Education as Topic ; Physician-Patient Relations ; Prostatic Neoplasms/therapy ; Qualitative Research ; Social Support
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?
Autorzy:
Chen MY; Wesley Hospital, Brisbane, Qld, Australia.; School of Medicine, University of Queensland, Brisbane, Qld, Australia.
Franklin A; Wesley Hospital, Brisbane, Qld, Australia.; School of Medicine, University of Queensland, Brisbane, Qld, Australia.
Yaxley J; Wesley Hospital, Brisbane, Qld, Australia.; School of Medicine, University of Queensland, Brisbane, Qld, Australia.
Gianduzzo T; Wesley Hospital, Brisbane, Qld, Australia.; School of Medicine, University of Queensland, Brisbane, Qld, Australia.
McBean R; Wesley Hospital, Brisbane, Qld, Australia.
Wong D; Wesley Hospital, Brisbane, Qld, Australia.
Tatkovic A; Wesley Hospital, Brisbane, Qld, Australia.
McEwan L; Wesley Hospital, Brisbane, Qld, Australia.
Walters J; Wesley Hospital, Brisbane, Qld, Australia.
Kua B; Wesley Hospital, Brisbane, Qld, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Sep; Vol. 126 (3), pp. 396-401. Date of Electronic Publication: 2020 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Oligopeptides*
Positron Emission Tomography Computed Tomography*/methods
Bone Diseases/*diagnostic imaging
Bone Neoplasms/*diagnostic imaging
Bone Neoplasms/*secondary
Edetic Acid/*analogs & derivatives
Prostatic Neoplasms/*pathology
Ribs/*diagnostic imaging
Aged ; Bone Diseases/etiology ; Cohort Studies ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/complications ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of clinically significant cancer in the anterior prostate by transperineal biopsy.
Autorzy:
Cowan T; Department of Urology, Ballarat Health Services, Ballarat Central, Victoria, Australia.
Baker E; Department of Urology, Ballarat Health Services, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
McCray G; Department of Urology, Ballarat Health Services, Ballarat Central, Victoria, Australia.
Reeves F; Department of Urology, Ballarat Health Services, Austin Hospital, Heidelberg, Victoria, Australia.
Houlihan K; Faculty of Health Medicine, Nursing and Behavioural Sciences, Deakin University, Burwood, Victoria, Australia.
Johns-Putra L; Department of Surgery, Ballarat Urology, Ballarat Health Services, Ballarat, Victoria, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Sep; Vol. 126 Suppl 1, pp. 33-37. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Biopsy, Needle/*methods
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Grading ; Perineum ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer.
Autorzy:
Roberts MJ; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.; Princess Alexandra Hospital, Brisbane, Qld, Australia.; Nepean Urology Research Group, Kingswood, NSW, Australia.
Papa N; Department of Urology, Austin Health, Heidelberg, Vic., Australia.
Perera M; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.; Princess Alexandra Hospital, Brisbane, Qld, Australia.; Department of Urology, Austin Health, Heidelberg, Vic., Australia.
Scott S; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.
Teloken PE; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia.
Joshi A; Princess Alexandra Hospital, Brisbane, Qld, Australia.; Australian Prostate Cancer Research Centre, Queensland University of Technology, Brisbane, Qld, Australia.
Vela I; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.; Princess Alexandra Hospital, Brisbane, Qld, Australia.; Australian Prostate Cancer Research Centre, Queensland University of Technology, Brisbane, Qld, Australia.
Pryor D; Princess Alexandra Hospital, Brisbane, Qld, Australia.; Australian Prostate Cancer Research Centre, Queensland University of Technology, Brisbane, Qld, Australia.
Martin J; Calvary Mater Newcastle, Waratah, NSW, Australia.
Woo H; Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, NSW, Australia.; Department of Uro-Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2019 Nov; Vol. 124 Suppl 1, pp. 31-36. Date of Electronic Publication: 2019 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Androgen Antagonists/*therapeutic use
Brachytherapy/*statistics & numerical data
Insurance Claim Review/*statistics & numerical data
Prostatectomy/*statistics & numerical data
Prostatic Neoplasms/*therapy
Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Australia/epidemiology ; Combined Modality Therapy ; Female ; Health Care Surveys ; Humans ; Male ; Middle Aged ; National Health Programs ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Radiotherapy Dosage ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 22

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies